Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$807M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$497M |
| 3 |
RNAM
Avidity Biosciences
RNAM
|
+$390M |
| 4 |
Kenvue
KVUE
|
+$379M |
| 5 |
Broadcom
AVGO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$409M |
| 2 |
Visa
V
|
+$354M |
| 3 |
Advanced Micro Devices
AMD
|
+$328M |
| 4 |
Meta Platforms (Facebook)
META
|
+$317M |
| 5 |
Lockheed Martin
LMT
|
+$316M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.61% |
| 2 | Consumer Discretionary | 9.64% |
| 3 | Healthcare | 8.17% |
| 4 | Industrials | 8.1% |
| 5 | Financials | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Weatherford International
WFRD
$6.49B
| $20.1M | 0.03% |
256,667
-511,039
| -67% | -$37.1M |
|
|
TTAN
677
ServiceTitan Inc
TTAN
$9.05B
| $20.1M | 0.03% |
188,485
+97,312
| +107% | +$9.51M |
|
|
BLD
678
DELISTED
TopBuild
BLD
| $20.1M | 0.03% |
48,079
+8,254
| +21% | +$3.54M |
|
|
GAP
679
CALL
The Gap Inc
GAP
$7.13B
| $20M | 0.03% |
783,100
+589,100
| +304% | +$14.3M |
|
680
DuPont de Nemours
DD
$18.7B
| $20M | 0.03% |
166,183
+22,468
| +16% | +$2.53M |
|
681
Neurocrine Biosciences
NBIX
$15.5B
| $20M | 0.03% |
141,101
-62,306
| -31% | -$9.03M |
|
682
T-Mobile US
TMUS
$196B
| $20M | 0.03% |
98,404
-1,182,736
| -92% | -$251M |
|
|
LBRX
683
LB Pharmaceuticals
LBRX
$1.54B
| $20M | 0.03% |
896,806
-71,468
| -7% | -$1.25M |
|
684
Nice
NICE
$5.87B
| $19.9M | 0.03% |
+176,474
| New | +$21.3M |
|
685
Verisk Analytics
VRSK
$24.4B
| $19.9M | 0.03% |
89,032
+49,625
| +126% | +$11.2M |
|
686
AutoNation
AN
$6.6B
| $19.7M | 0.03% |
+95,494
| New | +$19.9M |
|
687
PUT
Marvell Technology
MRVL
$213B
| $19.7M | 0.03% |
231,400
-30,900
| -12% | -$2.7M |
|
688
Qiagen
QGEN
$9.1B
| $19.6M | 0.02% |
436,782
-417,604
| -49% | -$19.3M |
|
|
689
Marvell Technology
MRVL
$213B
| $19.6M | 0.02% |
230,602
+217,932
| +1,720% | +$19.1M |
|
690
CALL
Carvana
CVNA
$76.9B
| $19.6M | 0.02% |
232,000
+24,500
| +12% | +$1.82M |
|
691
Axcelis
ACLS
$3.92B
| $19.6M | 0.02% |
243,503
+241,177
| +10,369% | +$20.2M |
|
692
Stanley Black & Decker
SWK
$15.1B
| $19.5M | 0.02% |
262,973
-757,860
| -74% | -$53.4M |
|
|
DEA
693
Easterly Government Properties
DEA
$1.16B
| $19.5M | 0.02% |
921,658
+64,554
| +8% | +$1.4M |
|
694
CALL
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.86B
| $19.5M | 0.02% |
154,500
-44,900
| -23% | -$5.82M |
|
695
Terex
TEX
$7.6B
| $19.5M | 0.02% |
+364,385
| New | +$18.4M |
|
696
Arcus Biosciences
RCUS
$3.86B
| $19.4M | 0.02% |
815,561
+715,188
| +713% | +$14.6M |
|
697
Abbott
ABT
$202B
| $19.4M | 0.02% |
+155,057
| New | +$19.8M |
|
698
UFP Industries
UFPI
$4.9B
| $19.4M | 0.02% |
213,320
+203,957
| +2,178% | +$18.7M |
|
|
HOUS
699
DELISTED
Anywhere Real Estate
HOUS
| $19.3M | 0.02% |
+1,364,727
| New | +$16.7M |
|
|
CYBR
700
PUT
DELISTED
CyberArk
CYBR
| $19.3M | 0.02% |
43,200
+3,200
| +8% | +$1.54M |
|
Similar funds
Dmitry Balyasny's Q4 2025 Portfolio in Review
As of Q4 2025, Dmitry Balyasny held 3,669 positions worth $78.8B, down 0.17% from $78.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Dmitry Balyasny withdrew a net $4.13B in Q4 2025, closing 643 positions and reducing 1,102 holdings. Its most notable exit was Mr. Cooper, an estimated $277M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Dmitry Balyasny opened a new position in Avidity Biosciences worth $436M.
- Dmitry Balyasny's largest Q4 2025 buy was Avidity Biosciences: 6,040,590 shares worth $436M.
- Dmitry Balyasny added most to Amazon in Q4 2025, an estimated $807M increase.
- Dmitry Balyasny's biggest Q4 2025 reduction was Apple, cutting an estimated $409M.
- Dmitry Balyasny fully exited Mr. Cooper in Q4 2025, selling an estimated $277M.
- Dmitry Balyasny's ten largest holdings make up 15% of its $78.8B portfolio in Q4 2025.
- Dmitry Balyasny opened 809 new positions and closed 643 in Q4 2025.
- Dmitry Balyasny's portfolio value fell 0.17% quarter-over-quarter to $78.8B.
Based on Balyasny Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.